CosmoInnovations has announced a series of manufacturing, partnership and industry milestones supporting the international expansion of its award-winning SkinGate™ platform and broader consumer-health technology portfolio.
Initial funding enabled the company to begin manufacturing its first 1,000 SkinGate Version 2 units. This transition into production is supported by a growing commercial network across Australia, Asia, the Middle East, Europe and the United States.
Strategic developments include a commercial access to the Chemist Warehouse Marketplace Portal and a distribution relationship with BeautyLounge and Advanced Cosmeceuticals (ANZ). Discussions and expressions of interest have also involved television-shopping platforms, international retailers and major global beauty companies exploring distribution, licensing, white-labelling and other strategic opportunities.
SkinGate’s industry recognition provides further validation of the platform.
The technology was named a finalist in the BeautyMatter 2025 Awards in New York for Best Breakthrough Technology—Supplier Side. SkinGate was also ranked fifth globally in the L’Oréal Beauty Innovation Runway at Slingshot Singapore, competing against more than 120 international technology companies.
As a graduate resident of JLABS, Johnson & Johnson Innovation, CosmoInnovations has benefited from participation in a leading global healthcare-innovation ecosystem. Together, these milestones strengthen the company’s pathway towards expanded manufacturing, international distribution and long-term commercial growth.
